Added to YB: 2026-02-24
Pitch date: 2026-02-23
HIK.L [neutral]
Hikma Pharmaceuticals PLC
+6.2%
current return
Author Info
Contrarian Cashflows publishes a monthly deep dive on a new value stock. Sign up for the newsletter.
Company Info
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
Market Cap
GBP 4.7B
Pitch Price
GBP 15.46
Price Target
N/A
Dividend
3.77%
EV/EBITDA
7.16
P/E
12.68
EV/Sales
1.86
Sector
Pharmaceuticals
Category
value
Monday Delight: 23/02/2026 - Hikma Pharmaceuticals PLC
HIK.L (quick overview): Multi-segment pharma (injectable, oral, branded generics) w/ 16.6% ROCE, positioned for pharma outsourcing trend. Profitable growth at undemanding 9.5x P/E. Key risk: capital allocation - mgmt deploys ~1/3 OCF to M&A w/ mixed results & recent write-downs.
Read full article (1 min)